[144] CALIX, INC. SEC Filing
Rhea-AI Filing Summary
Calix, Inc. insider sale notice: This Form 144 shows a proposed sale of 24,000 common shares to be executed through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $1,440,000. The securities were acquired the same day, 09/04/2025, by stock option exercise with cash paid on acquisition. The filer previously sold common shares on 08/28/2025 (126,000 shares, $7,560,000), 08/04/2025 (74,000 shares, $4,218,000), 07/23/2025 (108,000 shares, $6,064,000) and 07/22/2025 (92,000 shares, $5,060,000), as disclosed in the form. The filer certifies no undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Substantial insider selling disclosed over recent weeks; planned sale is smaller and stems from option exercise.
The filing reports a proposed sale of 24,000 shares acquired by stock option exercise on 09/04/2025 for cash, valued at $1.44 million. Material context comes from prior disposals: four sales between 07/22/2025 and 08/28/2025 totaling 400,000 shares with gross proceeds of $22,902,000. While the current planned sale is routine following option exercise, the pattern of concentrated dispositions by the same individual over a short period can be relevant to market participants evaluating insider activity and share supply dynamics.
TL;DR: Disclosure complies with Rule 144 format; signer affirms absence of undisclosed material information.
The Form 144 contains the required seller, broker and transaction details: broker identity, method of acquisition (stock option exercise), payment in cash, and clear listing of recent sales by the same person. The notice includes the statutory representation about no material nonpublic information. There is no indication in this filing of any trading plan date or reliance on Rule 10b5-1, and no additional governance issues are described within the text provided.